Rebiopsy and Acquired Mutations Following Progression in Non-Small Cell Lung Cancer
2 意见
• 07/14/23
0
0
嵌入
Anne S. Tsao, MD, Mark A. Socinski, MD, Corey J. Langer, MD, Alan B. Sandler, MD, and David Gandara, MD, discuss the need to perform a second biopsy to check for the loss or acquisition of mutations in non-small cell lung cancer following progression.
For more from this conversation: http://www.onclive.com/peer-ex....change/nsclc-advance
显示更多
脸书评论
SORT BY-
热门评论
-
最新评论